Deep Biologics Company
Deep Biologics utilizes AI-based methods to resolve the bottlenecks in developing specific and efficacious biologics for therapeutic and diagnostic purposes. We combine cutting edge in silico technologies with conventional screening, to deliver unprecedented depth, quality, and speed for your biologics discovery pipelines.
Connections
Founded Date:
2020-01-01 00:00:00
Technology:
Computational Drug Design & Virtual Screening
Headquarters:
Toronto,Ontario,Canada,North America
Funding Status:
private
Industry:
BioPharma AI